TreeWAS – Variant ID: rs537930

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.027	0.973	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.000	0.988	0.012
C49.3 Connective and soft tissue of thorax	0.000	0.988	0.012
C49.2 Connective and soft tissue of lower limb, including hip	0.000	0.989	0.011
C49.1 Connective and soft tissue of upper limb, including shoulder	0.000	0.989	0.011
C49.9 Connective and soft tissue, unspecified	0.000	0.989	0.011
C49.0 Connective and soft tissue of head, face and neck	0.000	0.990	0.010
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.009	0.991	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.000	0.991	0.009
C49.6 Connective and soft tissue of trunk, unspecified	0.000	0.991	0.009
C49.5 Connective and soft tissue of pelvis	0.000	0.991	0.009
C49.4 Connective and soft tissue of abdomen	0.000	0.991	0.009
C69.3 Choroid	0.009	0.991	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.009	0.991	0.000
Y45.1 Salicylates	0.009	0.991	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.009	0.991	0.000
Y45.2 Propionic acid derivatives	0.008	0.992	0.000
N99.8 Other postprocedural disorders of genito-urinary system	0.008	0.992	0.000
Y45.8 Other analgesics and antipyretics	0.008	0.992	0.000
C69 Malignant neoplasm of eye and adnexa	0.008	0.992	0.000
Y45.5 4-Aminophenol derivatives	0.008	0.992	0.000
C69.9 Eye, unspecified	0.008	0.992	0.000
I34.1 Mitral (valve) prolapse	0.008	0.992	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.008	0.992	0.000
K91.4 Colostomy and enterostomy malfunction	0.008	0.992	0.000
C43.5 Malignant melanoma of trunk	0.000	0.992	0.008
C69.6 Orbit	0.007	0.993	0.000
K91.0 Vomiting following gastro-intestinal surgery	0.007	0.993	0.000
Y45.0 Opioids and related analgesics	0.007	0.993	0.000
Y45.4 Antirheumatics	0.007	0.993	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.007	0.993	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.007	0.993	0.000
K91.1 Postgastric surgery syndromes	0.006	0.993	0.000
K91.5 Postcholecystectomy syndrome	0.006	0.994	0.000
C69.0 Conjunctiva	0.006	0.994	0.000
C69.8 Overlapping lesion of eye and adnexa	0.006	0.994	0.000
C69.5 Lachrymal gland and duct	0.006	0.994	0.000
C69.4 Ciliary body	0.006	0.994	0.000
C69.2 Retina	0.006	0.994	0.000
C69.1 Cornea	0.006	0.994	0.000
L73.2 Hidradenitis suppurativa	0.000	0.994	0.006
N99.4 Postprocedural pelvic peritoneal adhesions	0.006	0.994	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.000	0.994	0.006
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.006	0.994	0.000
L73.9 Follicular disorder, unspecified	0.000	0.995	0.005
L73 Other follicular disorders	0.000	0.995	0.005
C45.9 Mesothelioma, unspecified	0.000	0.995	0.005
K91.9 Postprocedural disorder of digestive system, unspecified	0.005	0.995	0.000
C45 Mesothelioma	0.000	0.995	0.005
L60.8 Other nail disorders	0.000	0.995	0.005
N99.5 Malfunction of external stoma of urinary tract	0.005	0.995	0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.005	0.995	0.000
N99.2 Postprocedural adhesions of vagina	0.005	0.995	0.000
N99.1 Postprocedural urethral stricture	0.004	0.995	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.000	0.995	0.004
C46 Kaposi's sarcoma	0.000	0.995	0.004
Y43.4 Immunosuppressive agents	0.004	0.996	0.000
L73.1 Pseudofolliculitis barbae	0.000	0.996	0.004
L73.0 Acne keloid	0.000	0.996	0.004
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.004	0.996	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.000	0.996	0.004
N99.0 Postprocedural renal failure	0.004	0.996	0.000
C45.2 Mesothelioma of pericardium	0.000	0.996	0.004
C45.1 Mesothelioma of peritoneum	0.000	0.996	0.004
L65.9 Nonscarring hair loss, unspecified	0.000	0.996	0.004
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.004	0.996	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.004	0.996	0.000
L73.8 Other specified follicular disorders	0.000	0.996	0.004
K91.3 Postoperative intestinal obstruction	0.004	0.996	0.000
L65 Other nonscarring hair loss	0.000	0.996	0.004
L60-L75 Disorders of skin appendages	0.000	0.996	0.004
C46.9 Kaposi's sarcoma, unspecified	0.000	0.996	0.003
C46.8 Kaposi's sarcoma of multiple organs	0.000	0.996	0.003
C46.7 Kaposi's sarcoma of other sites	0.000	0.996	0.003
C46.3 Kaposi's sarcoma of lymph nodes	0.000	0.996	0.003
C46.2 Kaposi's sarcoma of palate	0.000	0.996	0.003
C46.1 Kaposi's sarcoma of soft tissue	0.000	0.996	0.003
C46.0 Kaposi's sarcoma of skin	0.000	0.996	0.003
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.000	0.996	0.003
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.000	0.996	0.003
C47.6 Peripheral nerves of trunk, unspecified	0.000	0.996	0.003
C47.5 Peripheral nerves of pelvis	0.000	0.996	0.003
C47.4 Peripheral nerves of abdomen	0.000	0.996	0.003
C47.3 Peripheral nerves of thorax	0.000	0.996	0.003
C47.2 Peripheral nerves of lower limb, including hip	0.000	0.996	0.003
C47.1 Peripheral nerves of upper limb, including shoulder	0.000	0.996	0.003
C47.0 Peripheral nerves of head, face and neck	0.000	0.996	0.003
C48.0 Retroperitoneum	0.000	0.997	0.003
C70 Malignant neoplasm of meninges	0.003	0.997	0.000
C45.7 Mesothelioma of other sites	0.000	0.997	0.003
D17.6 Benign lipomatous neoplasm of spermatic cord	0.000	0.997	0.003
L71 Rosacea	0.000	0.997	0.003
C45.0 Mesothelioma of pleura	0.000	0.997	0.003
Y40.0 Penicillins	0.003	0.997	0.000
S92.40 Fracture of great toe (closed)	0.000	0.997	0.003
C71.1 Frontal lobe	0.003	0.997	0.000
L60 Nail disorders	0.000	0.997	0.003
L71.1 Rhinophyma	0.000	0.997	0.003
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.000	0.997	0.003
C71 Malignant neoplasm of brain	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
L70 Acne	0.000	0.997	0.003
J01.9 Acute sinusitis, unspecified	0.003	0.997	0.000
L03.2 Cellulitis of face	0.000	0.997	0.003
Y40.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
Y43 Primarily systemic agents	0.003	0.997	0.000
R57.0 Cardiogenic shock	0.003	0.997	0.000
C70.0 Cerebral meninges	0.003	0.997	0.000
L60.2 Onychogryphosis	0.000	0.997	0.003
D47.3 Essential (haemorrhagic) thrombocythaemia	0.003	0.997	0.000
L65.8 Other specified nonscarring hair loss	0.000	0.997	0.003
L65.2 Alopecia mucinosa	0.000	0.997	0.003
L65.1 Anagen effluvium	0.000	0.997	0.003
L65.0 Telogen effluvium	0.000	0.997	0.003
S92.4 Fracture of great toe	0.000	0.997	0.003
L75 Apocrine sweat disorders	0.000	0.997	0.003
L74 Eccrine sweat disorders	0.000	0.997	0.003
L67 Hair colour and hair shaft abnormalities	0.000	0.997	0.003
L64 Androgenic alopecia	0.000	0.997	0.003
L63 Alopecia areata	0.000	0.997	0.003
L62 Nail disorders in diseases classified elsewhere	0.000	0.997	0.003
S92.41 Fracture of great toe (open)	0.000	0.997	0.003
C71.3 Parietal lobe	0.003	0.997	0.000
Y40.6 Rifamycins	0.003	0.997	0.000
L66 Cicatricial alopecia [scarring hair loss]	0.000	0.997	0.003
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
L70.0 Acne vulgaris	0.000	0.997	0.003
L71.9 Rosacea, unspecified	0.000	0.997	0.003
L68 Hypertrichosis	0.000	0.997	0.003
C70.9 Meninges, unspecified	0.003	0.997	0.000
C70.1 Spinal meninges	0.003	0.997	0.000
N99.3 Prolapse of vaginal vault after hysterectomy	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.003	0.997	0.000
L50.9 Urticaria, unspecified	0.003	0.997	0.000
M89.9 Disorder of bone, unspecified	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
L71.8 Other rosacea	0.000	0.997	0.003
L71.0 Perioral dermatitis	0.000	0.997	0.003
C48.1 Specified parts of peritoneum	0.000	0.997	0.002
Q27.3 Peripheral arteriovenous malformation	0.000	0.997	0.003
Y40.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
L60.5 Yellow nail syndrome	0.000	0.997	0.002
L60.4 Beau's lines	0.000	0.997	0.002
C72.9 Central nervous system, unspecified	0.002	0.997	0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.002	0.997	0.000
C72.5 Other and unspecified cranial nerves	0.002	0.997	0.000
C72.4 Acoustic nerve	0.002	0.997	0.000
C72.3 Optic nerve	0.002	0.997	0.000
C72.2 Olfactory nerve	0.002	0.997	0.000
C72.1 Cauda equina	0.002	0.997	0.000
C72.0 Spinal cord	0.002	0.997	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.000	0.997	0.003
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.002	0.997	0.000
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.000	0.997	0.003
C48.2 Peritoneum, unspecified	0.000	0.997	0.002
Y40.4 Tetracyclines	0.002	0.997	0.000
Y40.2 Chloramphenicol group	0.002	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
T51.0 Ethanol	0.000	0.997	0.003
C71.7 Brain stem	0.002	0.997	0.000
C71.6 Cerebellum	0.002	0.997	0.000
C71.5 Cerebral ventricle	0.002	0.997	0.000
Y40.3 Macrolides	0.002	0.997	0.000
S90.9 Superficial injury of ankle and foot, unspecified	0.000	0.997	0.002
N99-N99 Other disorders of the genitourinary system	0.002	0.997	0.000
C71.0 Cerebrum, except lobes and ventricles	0.002	0.998	0.000
L70.8 Other acne	0.000	0.998	0.002
L70.5 Acne excoriee des jeunes filles	0.000	0.998	0.002
L70.4 Infantile acne	0.000	0.998	0.002
L70.3 Acne tropica	0.000	0.998	0.002
L70.2 Acne varioliformis	0.000	0.998	0.002
L70.1 Acne conglobata	0.000	0.998	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
R17 Unspecified jaundice	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
M89.98 Disorder of bone, unspecified (Other)	0.002	0.998	0.000
I71.0 Dissection of aorta [any part]	0.002	0.998	0.000
L60.1 Onycholysis	0.000	0.998	0.002
Q50.4 Embryonic cyst of Fallopian tube	0.000	0.998	0.002
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.000	0.998	0.002
L70.9 Acne, unspecified	0.000	0.998	0.002
L60.3 Nail dystrophy	0.000	0.998	0.002
L62.8 Nail disorders in other diseases classified elsewhere	0.000	0.998	0.002
L62.0 Clubbed nail pachydermoperiostosis	0.000	0.998	0.002
L63.9 Alopecia areata, unspecified	0.000	0.998	0.002
L63.8 Other alopecia areata	0.000	0.998	0.002
L63.2 Ophiasis	0.000	0.998	0.002
L63.1 Alopecia universalis	0.000	0.998	0.002
L63.0 Alopecia (capitis) totalis	0.000	0.998	0.002
L64.9 Androgenic alopecia, unspecified	0.000	0.998	0.002
L64.8 Other androgenic alopecia	0.000	0.998	0.002
L64.0 Drug-induced androgenic alopecia	0.000	0.998	0.002
L67.9 Hair colour and hair shaft abnormality, unspecified	0.000	0.998	0.002
L67.8 Other hair colour and hair shaft abnormalities	0.000	0.998	0.002
L67.1 Variations in hair colour	0.000	0.998	0.002
L67.0 Trichorrhexis nodosa	0.000	0.998	0.002
L74.9 Eccrine sweat disorder, unspecified	0.000	0.998	0.002
L74.8 Other eccrine sweat disorders	0.000	0.998	0.002
L74.4 Anhidrosis	0.000	0.998	0.002
L74.3 Miliaria, unspecified	0.000	0.998	0.002
L74.2 Miliaria profunda	0.000	0.998	0.002
L74.1 Miliaria crystallina	0.000	0.998	0.002
L74.0 Miliaria rubra	0.000	0.998	0.002
L75.9 Apocrine sweat disorder, unspecified	0.000	0.998	0.002
L75.8 Other apocrine sweat disorders	0.000	0.998	0.002
L75.2 Apocrine miliaria	0.000	0.998	0.002
L75.1 Chromhidrosis	0.000	0.998	0.002
L75.0 Bromhidrosis	0.000	0.998	0.002
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
L66.8 Other cicatricial alopecia	0.000	0.998	0.002
L66.4 Folliculitis ulerythematosa reticulata	0.000	0.998	0.002
L66.3 Perifolliculitis capitis abscedens	0.000	0.998	0.002
L66.2 Folliculitis decalvans	0.000	0.998	0.002
L66.1 Lichen planopilaris	0.000	0.998	0.002
L66.0 Pseudopelade	0.000	0.998	0.002
S06.5 Traumatic subdural haemorrhage	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
L68.9 Hypertrichosis, unspecified	0.000	0.998	0.002
L68.8 Other hypertrichosis	0.000	0.998	0.002
L68.3 Polytrichia	0.000	0.998	0.002
L68.2 Localised hypertrichosis	0.000	0.998	0.002
L68.1 Acquired hypertrichosis lanuginosa	0.000	0.998	0.002
M89.96 Disorder of bone, unspecified (Lower leg)	0.002	0.998	0.000
M89.99 Disorder of bone, unspecified (Site unspecified)	0.002	0.998	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.002	0.998	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.002	0.998	0.000
L66.9 Cicatricial alopecia, unspecified	0.000	0.998	0.002
M89.94 Disorder of bone, unspecified (Hand)	0.002	0.998	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.002	0.998	0.000
C71.9 Brain, unspecified	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
C71.4 Occipital lobe	0.002	0.998	0.000
L68.0 Hirsutism	0.000	0.998	0.002
Y58.0 BCG vaccine	0.002	0.998	0.000
M70.22 Olecranon bursitis-Upper arm	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.998	0.002
S90 Superficial injury of ankle and foot	0.000	0.998	0.002
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
M76.86 Other enthesopathies of lower limb, excluding foot (Lower leg)	0.002	0.998	0.000
L60.9 Nail disorder, unspecified	0.000	0.998	0.002
B16 Acute hepatitis B	0.000	0.998	0.002
R80 Isolated proteinuria	0.002	0.998	0.000
G91.1 Obstructive hydrocephalus	0.000	0.998	0.002
Y43.3 Other antineoplastic drugs	0.002	0.998	0.000
S92 Fracture of foot, except ankle	0.000	0.998	0.002
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
A63.0 Anogenital (venereal) warts	0.000	0.998	0.002
T78.2 Anaphylactic shock, unspecified	0.000	0.998	0.002
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
S92.5 Fracture of other toe	0.000	0.998	0.002
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
S90.3 Contusion of other and unspecified parts of foot	0.000	0.998	0.002
S90.0 Contusion of ankle	0.000	0.998	0.002
B18.2 Chronic viral hepatitis C	0.000	0.998	0.002
J01 Acute sinusitis	0.002	0.998	0.000
S92.7 Multiple fractures of foot	0.000	0.998	0.002
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
U80.1 Methicillin resistant agent	0.000	0.998	0.002
S92.50 Fracture of other toe (closed)	0.000	0.998	0.002
E13.9 Without complications	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
C71.2 Temporal lobe	0.002	0.998	0.000
J01.4 Acute pansinusitis	0.002	0.998	0.000
O14.0 Moderate preeclampsia	0.002	0.998	0.000
Q27 Other congenital malformations of peripheral vascular system	0.000	0.998	0.002
S92.51 Fracture of other toe (open)	0.000	0.998	0.002
S90.7 Multiple superficial injuries of ankle and foot	0.000	0.998	0.002
S90.2 Contusion of toe(s) with damage to nail	0.000	0.998	0.002
S90.1 Contusion of toe(s) without damage to nail	0.000	0.998	0.002
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
B18 Chronic viral hepatitis	0.000	0.998	0.002
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
S91.3 Open wound of other parts of foot	0.000	0.998	0.002
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
S92.70 Multiple fractures of foot (closed)	0.000	0.998	0.002
B16.2 Acute hepatitis B without delta-agent with hepatic coma	0.000	0.998	0.002
B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma	0.000	0.998	0.002
B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma	0.000	0.998	0.002
S90.8 Other superficial injuries of ankle and foot	0.000	0.998	0.002
B17.1 Acute hepatitis C	0.000	0.998	0.002
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
J32.8 Other chronic sinusitis	0.000	0.998	0.002
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.000	0.998	0.002
S00.2 Other superficial injuries of eyelid and periocular area	0.000	0.998	0.002
S92.9 Fracture of foot, unspecified	0.000	0.998	0.002
Y59.3 Immunoglobulin	0.001	0.998	0.000
D47.4 Osteomyelofibrosis	0.002	0.998	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.002	0.998	0.000
N87.0 Mild cervical dysplasia	0.000	0.998	0.002
Y48.5 Therapeutic gases	0.001	0.998	0.000
Y48.1 Parenteral anaesthetics	0.001	0.998	0.000
Y48.0 Inhaled anaesthetics	0.001	0.998	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.002	0.998	0.000
M76.67 Achilles tendinitis (Ankle and foot)	0.002	0.998	0.000
B18.1 Chronic viral hepatitis B without delta-agent	0.000	0.998	0.002
I34 Nonrheumatic mitral valve disorders	0.002	0.998	0.000
S91 Open wound of ankle and foot	0.000	0.998	0.002
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
B17 Other acute viral hepatitis	0.000	0.998	0.002
F60.7 Dependent personality disorder	0.002	0.998	0.000
J01.8 Other acute sinusitis	0.001	0.998	0.000
J01.3 Acute sphenoidal sinusitis	0.001	0.998	0.000
J01.2 Acute ethmoidal sinusitis	0.001	0.998	0.000
J01.1 Acute frontal sinusitis	0.001	0.998	0.000
S92.2 Fracture of other tarsal bone(s)	0.000	0.998	0.001
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
O14.9 Preeclampsia, unspecified	0.002	0.998	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.000	0.998	0.002
S91.1 Open wound of toe(s) without damage to nail	0.000	0.998	0.002
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
S92.71 Multiple fractures of foot (open)	0.000	0.998	0.001
F60.9 Personality disorder, unspecified	0.002	0.998	0.000
D37.7 Other digestive organs	0.002	0.998	0.000
Q27.4 Congenital phlebectasia	0.000	0.998	0.001
Q27.2 Other congenital malformations of renal artery	0.000	0.998	0.001
Q27.1 Congenital renal artery stenosis	0.000	0.998	0.001
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.000	0.998	0.001
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.998	0.000
Y41.4 Anthelminthics	0.001	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.998	0.000
B15-B19 Viral hepatitis	0.000	0.998	0.002
B18.9 Chronic viral hepatitis, unspecified	0.000	0.998	0.001
B18.8 Other chronic viral hepatitis	0.000	0.998	0.001
B18.0 Chronic viral hepatitis B with delta-agent	0.000	0.998	0.001
Q27.8 Other specified congenital malformations of peripheral vascular system	0.000	0.998	0.001
Y48.4 Anaesthetic, unspecified	0.001	0.998	0.000
N28.1 Cyst of kidney, acquired	0.002	0.998	0.000
S92.1 Fracture of talus	0.000	0.998	0.001
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
Y53.7 Emetics	0.001	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.998	0.000
Y53.5 Digestants	0.001	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.998	0.000
Y53.2 Stimulant laxatives	0.001	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.998	0.000
Y41.5 Antiviral drugs	0.001	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.001	0.998	0.000
F60.5 Anankastic personality disorder	0.001	0.998	0.000
Y46.8 Antispasticity drugs	0.001	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.998	0.000
Y46.5 Valproic acid	0.001	0.998	0.000
Y46.3 Deoxybarbiturates	0.001	0.998	0.000
Y46.1 Oxazolidinediones	0.001	0.998	0.000
Y46.0 Succinimides	0.001	0.998	0.000
S90-S99 Injuries to the ankle and foot	0.000	0.998	0.002
S92.91 Fracture of foot, unspecified (open)	0.000	0.999	0.001
S92.90 Fracture of foot, unspecified (closed)	0.000	0.999	0.001
E85.9 Amyloidosis, unspecified	0.001	0.999	0.000
G91.2 Normal-pressure hydrocephalus	0.000	0.999	0.001
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.999	0.001
N28.8 Other specified disorders of kidney and ureter	0.001	0.999	0.000
F60 Specific personality disorders	0.001	0.999	0.000
Z01.6 Radiological examination, not elsewhere classified	0.000	0.999	0.001
Y44 Agents primarily affecting blood constituents	0.001	0.999	0.000
G91.8 Other hydrocephalus	0.000	0.999	0.001
S91.7 Multiple open wounds of ankle and foot	0.000	0.999	0.001
S91.2 Open wound of toe(s) with damage to nail	0.000	0.999	0.001
Y41.0 Sulphonamides	0.001	0.999	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.999	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.999	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.999	0.001
B17.9 Acute viral hepatitis, unspecified	0.000	0.999	0.001
B17.8 Other specified acute viral hepatitis	0.000	0.999	0.001
B17.2 Acute hepatitis E	0.000	0.999	0.001
B17.0 Acute delta-(super) infection of hepatitis B carrier	0.000	0.999	0.001
O14.1 Severe preeclampsia	0.001	0.999	0.000
S92.21 Fracture of other tarsal bone(s) (open)	0.000	0.999	0.001
C60.9 Penis, unspecified	0.001	0.999	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.001	0.999	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.001	0.999	0.000
J05.1 Acute epiglottitis	0.001	0.999	0.000
M76.8 Other enthesopathies of lower limb, excluding foot	0.001	0.999	0.000
S93.0 Dislocation of ankle joint	0.000	0.999	0.001
Y49.9 Psychotropic drug, unspecified	0.001	0.999	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.999	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.999	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.999	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.999	0.000
B15 Acute hepatitis A	0.000	0.999	0.001
S02.30 Fracture of orbital floor (closed)	0.000	0.999	0.001
D47.2 Monoclonal gammopathy	0.001	0.999	0.000
N95.1 Menopausal and female climacteric states	0.000	0.999	0.001
S92.3 Fracture of metatarsal bone	0.000	0.999	0.001
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.001	0.999	0.000
Y46.6 Other and unspecified antiepileptics	0.001	0.999	0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.001	0.999	0.000
Y57 Other and unspecified drugs and medicaments	0.001	0.999	0.000
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.001	0.999	0.000
F43.1 Posttraumatic stress disorder	0.000	0.999	0.001
R57.2 Septic shock	0.001	0.999	0.000
S00.1 Contusion of eyelid and periocular area	0.000	0.999	0.001
X45.0 Home	0.001	0.999	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.001	0.999	0.000
M62.88 Other specified disorders of muscle (Other)	0.000	0.999	0.001
S92.11 Fracture of talus (open)	0.000	0.999	0.001
F60.8 Other specific personality disorders	0.001	0.999	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.001	0.999	0.000
G91 Hydrocephalus	0.000	0.999	0.001
R57 Shock, not elsewhere classified	0.001	0.999	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.001	0.999	0.000
N92.1 Excessive and frequent menstruation with irregular cycle	0.000	0.999	0.001
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.999	0.000
S98 Traumatic amputation of ankle and foot	0.000	0.999	0.001
S95 Injury of blood vessels at ankle and foot level	0.000	0.999	0.001
S94 Injury of nerves at ankle and foot level	0.000	0.999	0.001
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level	0.000	0.999	0.001
F60.4 Histrionic personality disorder	0.001	0.999	0.000
F60.2 Dissocial personality disorder	0.001	0.999	0.000
F60.1 Schizoid personality disorder	0.001	0.999	0.000
F60.0 Paranoid personality disorder	0.001	0.999	0.000
G71.0 Muscular dystrophy	0.001	0.999	0.000
I34.8 Other nonrheumatic mitral valve disorders	0.001	0.999	0.000
S93.3 Dislocation of other and unspecified parts of foot	0.000	0.999	0.001
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.999	0.001
Y46.4 Iminostilbenes	0.001	0.999	0.000
I34.0 Mitral (valve) insufficiency	0.001	0.999	0.000
J01.0 Acute maxillary sinusitis	0.001	0.999	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.999	0.000
Y44.7 Plasma substitutes	0.001	0.999	0.000
Y44.6 Natural blood and blood products	0.001	0.999	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.001	0.999	0.000
B19 Unspecified viral hepatitis	0.000	0.999	0.001
Y51 Drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.000	0.999	0.001
F23.9 Acute and transient psychotic disorder, unspecified	0.000	0.999	0.001
G91.0 Communicating hydrocephalus	0.000	0.999	0.001
L50.1 Idiopathic urticaria	0.001	0.999	0.000
S91.0 Open wound of ankle	0.000	0.999	0.001
Y46.2 Hydantoin derivatives	0.001	0.999	0.000
Y53.4 Other laxatives	0.001	0.999	0.001
M76.89 Other enthesopathies of lower limb, excluding foot-Site uns	0.001	0.999	0.000
M76.88 Other enthesopathies of lower limb, excluding foot-Other	0.001	0.999	0.000
M76.85 Other enthesopathies of lower limb, excluding foot (Pelvic region and thigh)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations